文献速递神经眼科小儿眼科与斜弱视

儿童与成人视神经炎的人群发病率及多发性硬化风险

Population-based Incidence of Pediatric and Adult Optic Neuritis and the Risk of Multiple Sclerosis.
PubMed 文献 · Ophthalmology · 2019-09-27

PURPOSE: To determine the age- and sex-specific prevalence and incidence of demyelinating optic neuritis and the risk of multiple sclerosis (MS) in pediatric and adult populations in South Korea.…

要点

  • 儿童视神经炎年发病率为1.04/10万,成人为3.29/10万。
  • 儿童多发性硬化转化率为13.8%,成人为11.4%。
  • 14%患者接受慢性免疫抑制治疗,38%NMO患者行血浆置换。

核心结论

  • 韩国儿童视神经炎发病率及多发性硬化风险与西方国家相当,但成人发病率低于西方国家。

研究设计与样本

  • 全国性、基于人群的回顾性研究,使用2010至2016年韩国国民健康保险索赔数据库。
  • 14岁及以下归类为儿童,15至65岁归类为成人,分组分析。

主要发现

  • 共识别531例儿童视神经炎患者(女性50.7%)和7183例成人患者(女性53.3%)。
  • 儿童年发病率为1.04(95%CI 1.01-1.07)/10万,成人为3.29(95%CI 3.28-3.30)/10万。
  • 儿童发病率峰值在10-14岁,成人峰值在30-34岁和50-54岁。
  • 儿童多发性硬化转化率为13.8%,成人为11.4%。
  • 14%所有患者接受慢性免疫抑制治疗,38%NMO患者行血浆置换,50%MS患者接受干扰素-β治疗。

关键数值与推荐

  • 儿童视神经炎年发病率1.04(95%CI 1.01-1.07)/10万。
  • 成人视神经炎年发病率3.29(95%CI 3.28-3.30)/10万。
  • 儿童多发性硬化转化率13.8%,成人11.4%。
  • 成人发病率是儿童的3.2倍,韩国全人群多发性硬化转化率估计为10.6%。

临床怎么用

  • 儿童与成人视神经炎发病率及多发性硬化转化风险存在差异,临床评估需年龄分层。
  • NMO患者中38%需血浆置换,MS患者中50%使用干扰素-β,提示治疗模式可参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the age- and sex-specific prevalence and incidence of demyelinating optic neuritis and the risk of multiple sclerosis (MS) in pediatric and adult populations in South Korea. DESIGN: A nationwide, population-based, retrospective study using data from the Korean National Health Claims database from 2010 to 2016. PARTICIPANTS: The entire South Korean population aged 65 years of age or younger (n = 44 700 564). All patients with optic neuritis from the entire Korean population were included. METHODS: Patients aged 14 years of age or younger were classified as pediatric patients, and those aged 15 to 65 years were classified as adults. Each group was analyzed separately. Patients with optic neuritis had a subsequent diagnosis, including idiopathic, MS, neuromyelitis optica (NMO), and acute disseminated encephalomyelitis. Prevalence and incidence, conversion rate to MS, and treatment modalities (steroids, plasmapheresis, interferon-β, and immunosuppressants) were estimated. MAIN OUTCOME MEASURES: Prevalence and incidence of optic neuritis, and conversion rate to MS. RESULTS: Among 44 700 564 individuals, 531 pediatric patients (50.7% female) and 7183 adults (53.3% female) were identified as having optic neuritis. Annual incidence was 1.04 (95% confidence interval [CI], 1.01-1.07) per 100 000 pediatric individuals and 3.29 (95% CI, 3.28-3.30) per 100 000 adults. Peak incidence was observed at 10 to 14 years in the pediatric population and at 30 to 34 years and 50 to 54 years in the adult population. Conversion rate to MS was 13.8% in the pediatric population and 11.4% in the adult population. Fourteen percent of all patients were treated with chronic immunosuppressants, 38% of patients with NMO underwent plasmapheresis, and 50% of patients with MS were treated with interferon-β. CONCLUSIONS: This is a nationwide epidemiologic study of optic neuritis in individuals of all ages in South Korea. The incidence of optic neuritis and subsequent risk of MS in the pediatric population are comparable to those reported in western countries but are lower in the adult population than in western countries. The incidence rate in adults was 3.2-fold higher than in the pediatric population, and the overall MS conversion rate in the entire Korean population was estimated to be 10.6%.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Lee JY, Han J, Yang M, et al. Population-based Incidence of Pediatric and Adult Optic Neuritis and the Risk of Multiple Sclerosis. Ophthalmology. 2019. PMID: 31732227. doi:10.1016/j.ophtha.2019.09.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。